MedTrace Logo

A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth

NCT03106792 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2018-07-10

No results posted yet for this study

Summary

The primary outcome of the study is the effect of Hairfinity vs. Placebo on the rate of distal hair growth, assessed using Trichoscan HD, in healthy female adults from baseline to day 90 (end of study).

Conditions

  • Healthy Participants

Interventions

DIETARY_SUPPLEMENT

Hairfinity #1

Main Hairfinity formulation

DIETARY_SUPPLEMENT

Hairfinity #2

Variation to main formulation

DIETARY_SUPPLEMENT

Hairfinity #3

Variation to main formulation

DIETARY_SUPPLEMENT

Placebo

No active ingredients

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Brock Beauty Inc.

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-24
Primary Completion
2018-06-29
Completion
2018-06-29

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106792 on ClinicalTrials.gov